ABZENA
Abzena (AIM: ABZA) provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products, a growing area that requires specialist knowledge and expertise. The Group has a global customer base which includes the majority of the top 20 biopharmaceutical companies as well as large and small biotech companies and academic groups. The term “Abzena inside” is used by Abzena to describe products that have been created using its propr... ietary technologies and are being developed by its partners, and include Composite Human Antibodies™ and ThioBridge™ Antibody Drug Conjugates (ADCs). Abzena has the potential to earn future licence fees, milestone payments and/or royalties on “Abzena inside” products. Abzena offers the following services and technologies across its sites in Cambridge (UK), San Diego, California (USA) and Bristol, Pennsylvania (USA). •Immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins, and cell line development for manufacture. •Contract process development and manufacture of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapy and cell therapy products, for preclinical and clinical studies. •Proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimizing the therapeutic properties of biopharmaceuticals. •Contract chemistry and bioconjugation business focused on ADCs and is establishing the capability to manufacture ADCs to GMP standards
ABZENA
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2002-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.abzena.com
Total Employee:
101+
Status:
Active
Contact:
215-788-3603
Email Addresses:
[email protected]
Total Funding:
139.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-11-24 | The Chemistry Research Solution | The Chemistry Research Solution acquired by Abzena | N/A |
| 2015-09-14 | PacificGMP (now Abzena) | PacificGMP (now Abzena) acquired by Abzena | 7.7 M USD |
| 2013-07-29 | Antitope Ltd | Antitope Ltd acquired by Abzena | N/A |
| 2013-07-29 | PolyTherics | PolyTherics acquired by Abzena | N/A |
Investors List
Welsh Carson Anderson & Stowe
Welsh Carson Anderson & Stowe investment in Private Equity Round - Abzena
Biospring Partners
Biospring Partners investment in Private Equity Round - Abzena
Biospring Partners
Biospring Partners investment in Private Equity Round - Abzena
ProVen VCT
ProVen VCT investment in Post-IPO Equity - Abzena
Catapult Ventures
Catapult Ventures investment in Venture Round - Abzena
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-21 | Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina |
Official Site Inspections
http://www.abzena.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.61 K
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abzena"
Abzena Corporate Brochure
Moving medicine forward. At Abzena, our focus is on providing a de-risked and streamlined development pathway for our customers. As the leading CDMO + CRO for complex biologics …See details»
Abzena | Bioconjugates & Biologics CDMO+CRO
End-to-End Support Under One Organization; Abzena are advocates and partners for our customers’ success. We are a bioconjugate and biologics-focused CDMO + CRO partner with: ... Abzena is the major sponsor of the …See details»
Abzena Company Profile | Management and Employees List
Abzena Profile and History Abzena is a leading partner research organization that offers integrated discovery, development and cGMP manufacture services for biologics and …See details»
Abzena - Crunchbase Company Profile & Funding
Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and …See details»
Abzena - LinkedIn
Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual ...See details»
Abzena - Drug Development and Delivery
Nov 16, 2023 Abzena is the leading end-to-end CDMO + CRO for bioconjugates, ADCs and complex biologics. From discovery through commercial launch, we support customers with fully integrated programs or individual …See details»
Abzena - Biocom CRO
Abzena is the leading end-to-end bioconjugate, Antibody-drug conjugate (ADC), and complex biologics CDMO + CRO. From early discovery through commercial launch, we support …See details»
Abzena - Overview, News & Similar companies | ZoomInfo.com
Abzena is a leading partner research organization that offers integrated discovery, development and cGMP manufacture services for biologics and bio conjugates. Abzena provides the most …See details»
Abzena Company Profile - Office Locations, Competitors, Revenue …
Abzena (formerly known as PolyTherics) is a contract manufacturing organization that develops biopharmaceuticals. It specializes in antibody discovery, design, and engineering, formulation …See details»
Abzena Company Profile 2024: Valuation, Funding
Abzena General Information Description. Provider of outsourced research, development, and manufacturing services focused on biologics and antibody-drug conjugates. The company offers contract development, screening, …See details»
ABOUT ABZENA - bioprocessonline.com
Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or …See details»
Abzena Mission, Benefits, and Work Culture | Indeed.com
Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. Abzena provides proprietary technologies and complementary services to …See details»
Mission & Values - Abzena
Led by science, Abzena is designed for innovation. Our guiding values and mission allow us to help our customers move medicine forward. ... End-to-End Support Under One Organization. …See details»
Partnering - Why Abzena?
At Abzena, our unique structure and our values help us build collaborative and long-lasting relationships with our partners. We believe partnering with other organizations allows scientific …See details»
Abzena | Top Contract Manufacturing organizations-2024
Abzena’s expertise in cutting-edge ADC programs ensured clinical success and propelled the customer’s ADC oncology product to Phase III. Ultimately, the biopharma customer expanded …See details»
Abzena - Funding, Financials, Valuation & Investors - Crunchbase
Abzena is registered under the ticker LSE:ABZA . Abzena is funded by 4 investors. Welsh Carson Anderson & Stowe and Biospring Partners are the most recent investors. Abzena has acquired …See details»
Abzena's History | Abzena Timeline | Better Biologics
Abzena have a rich 20+ year history in biologics, stemming from being founded in 2001 by Steve Brocchini and Sunil Shaunak. ... ADCs, providing customers a fully integrated offering from …See details»
Abzena nabs $65M to bolster manufacturing and research services …
Apr 12, 2022 The partner research organization has collected $65 million from Welsh, Carson, Anderson & Stowe plus Biospring Partners and other investors, Abzena said in a recent …See details»
Biologic & Bioconjugate Solutions - Abzena
Abzena are uniquely positioned, and ready to partner with you, to move your complex biologic or bioconjugate and ADC program’s forwards. When you partner with us, expect: Access to …See details»